# Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

> **NCT00490659** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 13 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** cisplatin
- **PROCEDURE:** radical surgery
- **PROCEDURE:** chemoradiotherapy

## Key facts

- **NCT ID:** NCT00490659
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2007-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490659, "Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00490659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*